Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Autors principals: | Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V |
---|---|
Format: | Conference item |
Idioma: | English |
Publicat: |
Wiley
2019
|
Ítems similars
-
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
per: Chen, W, et al.
Publicat: (2018) -
Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
per: Xue, L, et al.
Publicat: (2018) -
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
per: Hardman, C, et al.
Publicat: (2019) -
Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
per: Xue, L, et al.
Publicat: (2019) -
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
per: Hardman, CS, et al.
Publicat: (2021)